profile-img
Tom Powles

@tompowles1

Interested in Urology Cancers, biomarkers and drug development.

calendar_today16-12-2019 14:24:22

1,2K Tweets

10,6K Followers

58 Following

Tom Powles(@tompowles1) 's Twitter Profile Photo
Tom Powles
@tompowles1

3 weeks ago

Data from the control arm of adjuvant bladder cancer trials (CM274 and Ambassador250) suggests ~35% get no further therapy after relapse (accounting for censoring). Excellent sites. Chemo is globally available. Regular CT follow should catch early & treat. Any easy explanations?

Data from the control arm of adjuvant bladder cancer trials (CM274 and Ambassador250) suggests ~35% get no further therapy after relapse (accounting for censoring). Excellent sites. Chemo is globally available. Regular CT follow should catch early & treat. Any easy explanations?
account_circle